Dr. Budelier the Medical Director of Clinical Chemistry and Toxicology at TriCore Reference Laboratories and Clinical Assistant Professor of Pathology at the University of New Mexico. Her research interests are broadly focused on developing clinically useful, mass spectrometry-based assays to improve diagnosis and treatment of human disease. Her expertise are in Toxicology/TDM, assay development and validation, and protein quantification.

Dr. Grant earned a first-class honors degree in Industrial Chemistry from Cardiff University and a PhD in Chromatographic and Mass Spectrometric technologies from the University of Swansea, Wales, United Kingdom. He continued his scientific training in various industrial settings, which have included senior scientist at GSK, Principal scientist at Cohesive Technologies, Technical director at Eli Lilly, and Director of Mass Spectrometry at Esoterix Endocrinology. Dr Grant is currently the Vice President of Research and Development and co-discipline director for Mass spectrometry at Labcorp. Dr Grant has pioneered the use of direct injection technologies, chromatographic systems multiplexing, microsampling, utility of automation, and other new analytical platforms in direct patient care. His research goals are focused upon improvements in speed, sensitivity, and quality of liquid chromatography with tandem mass spectrometric (LC-MS/MS) analytical systems and assays. Dr Grant has been awarded 100 patents and received both the MSACL Distinguished contribution award and ASMS AL Yergey “Unsung Hero” Award in 2024 for his contributions to Clinical Diagnostics using Mass Spectrometry.

Dr. Elenitoba-Johnson is the inaugural Chair of the Department of Pathology and Laboratory Medicine, and Member of the Human Oncology & Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center. Prior to this appointment, he was the Director of the Center of Personalized Diagnostics, and the inaugural Peter C. Nowell, M.D., Endowed Professor, in the Department of Pathology and Laboratory Medicine at Penn Medicine, Perelman School of Medicine, at the University of Pennsylvania from 2015 to August 2022.

He is a recognized pioneer in lymphoma proteomics, and a top leader in precision and integrated diagnostics. His work is notable for the identification and mechanistic elucidation of targetable genetic alterations underlying the pathogenesis of specific lymphoma subtypes. Dr. Elenitoba-Johnson has contributed to over 180 peer-reviewed manuscripts, numerous chapters and text books. His research is supported by 3 RO1 awards from the National Institutes of Health.

Dr. Elenitoba-Johnson is an elected member of the National Academy of Medicine, the American Society for Clinical Investigation and the International Lymphoma Study Group. (2017) and has been recognized with numerous professional honors and awards, notably the Ramzi Cotran Young Investigator Award from the United States and Canadian Academy of Pathology, the Outstanding Investigator (Former Warner-Lambert-Parke Davis) Award from the American Society for Investigative Pathology and the William Gerald Award from Memorial Sloan Kettering Cancer Center.

Wiebke Arlt is the Director of the Medical Research Council Laboratory of Medical Sciences (LMS) and Professor of Transdisciplinary Medicine at Imperial College London; she also serves as Honorary Consultant Endocrinologist at Imperial College Healthcare Trust, with a clinical focus on adrenal and reproductive endocrinology.

At the LMS, she leads a multi-disciplinary research group comprising biochemists, clinician scientists and computational biologists, investigating the role of steroids in health and disease, with a focus on the link between steroids and metabolism. Her group uses steroid mass spectrometry in combination with in vitro, ex vivo and in vivo phenotyping in humans as a discovery tool and for the development of biomarkers utilised for diagnostic and prognostic test purposes.

Wiebke has published over 250 original research articles and is a sought-after lecturer. Her scientific work has attracted major international prizes, most recently the 2021 Keith Harrison Memorial Lecture of the Endocrine Society of Australia, the 2019 Outstanding Clinical Investigator Award of the Endocrine Society USA, the 2017 Berthold Medal of the German Endocrine Society, and the 2016 Clinical Endocrinology Trust Medal of the European Society of Endocrinology. She was elected Fellow of the UK Academy of Medical Sciences in 2010 and currently serves on the Academy’s Council.

R. Graham Cooks is the Henry Bohn Hass Distinguished Professor in the Department of Chemistry at Purdue University. He has served as major professor to 150 PhD students. Dr. Cooks’ was a pioneer in the conception and implementation of tandem mass spectrometry (MS/MS) and of desorption ionization, especially molecular secondary ionization mass spectrometry (SIMS). His work also includes the development of miniature portable mass spectrometers using ambient ionization and application of this combination to problems of trace chemical analysis at point-of-care. His interests in the fundamentals of ion chemistry focus on chiral analysis based on the kinetics of cluster ion fragmentation. His group also studies collisions of ions at surfaces for new methods of molecular surface tailoring and analysis, and nanomaterials preparation by soft-landing of ions and charged droplets. Dr. Cooks also launched new methods of small scale synthesis based on accelerated reactions in microdroplets and incorporated this capability into high throughput screening instrumentation based on DESI. This screening capability extends to enzyme assays. Dr. Cooks has been recognized with the Mass Spectrometry and the Analytical Chemistry awards of the American Chemical Society, the Robert Boyle Medal and the Centennial Prize of the Royal Society of Chemistry, and the Camille & Henry Dreyfus Prize in the Chemical Sciences. He is an elected fellow of the American Academy of Arts and Sciences, the Academy of Inventors and the U.S. National Academy of Sciences.